Europe Veterinary Pain Management Market - Industry Trends and Forecast to 2032

Description

List of Tables

Europe veterinary pain management market is expected to reach USD 779,744.79 thousand by 2030 from USD 535,409.78 thousand in 2022 growing at a CAGR of 5.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation

Europe Veterinary Pain Management Market, By Product Type (Analgesics, Corticosteroids, and Alpha 2 Agonists), Drug Type (Branded and Generic), Mode of Purchase (Prescription Based and OTC), Animal Type (Companion Animal and Production Animal), Pain Source (Chronic Pain, Acute Pain, Post-Operative Pain, and Dental Pain), Dosage (Solid, Liquid, and Semi-Solid), Route of Administration (Parenteral, Oral, and Topical), End User (Veterinary Hospitals, Veterinary Clinics, Pet Shops, Animal Farms, Academic & Research Institutes, and Others), Country (Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Belgium, Turkey, Poland, Denmark, Sweden, Norway, Funland, and rest of Europe) - Industry Trends and Forecast to 2030.

Overview of Europe Veterinary Pain Management Market Dynamics

Driver
Rising incidences of pet diseases
Restraint
High costs of pet care
Opportunity
Technological advancements for pain management

Market Players

Some of the major market players operating in the Europe veterinary pain management market are listed below:

Dechra Pharmaceuticals PLC
Virbac
Norbrook
Durvet Animal Health Products
Bimeda, Inc.
Inovet ( A subsidiary of Orion Group)
Chanelle Pharma
Vetoquinol
Elanco
Merck & Co., Inc.
Zoetis Services LLC
Ceva Animal Health, LLC

1 INTRODUCTION 29

1.1 OBJECTIVES OF THE STUDY 29
1.2 MARKET DEFINITION 29
1.3 OVERVIEW OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET 29
1.4 CURRENCY AND PRICING 31
1.5 LIMITATIONS 31
1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 35

2.1 MARKETS COVERED 35
2.2 GEOGRAPHICAL SCOPE 36
2.3 YEARS CONSIDERED FOR THE STUDY 37
2.4 DBMR TRIPOD DATA VALIDATION MODEL 38
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 41
2.6 MULTIVARIATE MODELLING 42
2.7 MARKET END USER COVERAGE GRID 42
2.8 PRODUCT LIFELINE CURVE 43
2.9 DBMR MARKET POSITION GRID 44
2.10 VENDOR SHARE ANALYSIS 45
2.11 SECONDARY SOURCES 46
2.12 ASSUMPTIONS 46

3 EXECUTIVE SUMMARY 47

4 PREMIUM INSIGHTS 50

4.1 PESTEL ANALYSIS 51
4.2 PORTER'S FIVE FORCES 52
4.3 BRAND REVENUE ANALYSIS 53

5 MARKET OVERVIEW 54

5.1 DRIVERS 56
- 5.1.1 INCREASING PET OWNERSHIP 56
- 5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 56
- 5.1.3 GROWING INCIDENCES OF PET DISEASES 57
- 5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 57
5.2 RESTRAINTS 58
- 5.2.1 INCREASING PET CARE COSTS 58
- 5.2.2 STRICT REGULATORY GUIDELINES 58
5.3 OPPORTUNITIES 59
- 5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 59
- 5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 60
- 5.3.3 TECHNOLOGICAL ADVANCEMENTS 60
5.4 CHALLENGES 61
- 5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 61
- 5.4.2 RESISTANCE TO MEDICATIONS 61

6 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 62

6.1 OVERVIEW 63
6.2 ANALGESICS 64
- 6.2.1 ANTI- INFLAMMATORY (NSAIDS) 64
  - 6.2.1.1 CARPROFEN 65
  - 6.2.1.2 MELOXICAM 65
  - 6.2.1.3 PHENYLBUTAZONE 65
  - 6.2.1.4 ACETAMINOPHEN 65
  - 6.2.1.5 FIROCOXIB 65
  - 6.2.1.6 DERACOXIB 65
  - 6.2.1.7 OTHERS 66
- 6.2.2 OPIOIDS 66
  - 6.2.2.1 MU AGONISTS 66
    - 6.2.2.1.1 METHADONE 67
    - 6.2.2.1.2 MEPERIDINE 67
    - 6.2.2.1.3 MORPHINE 67
    - 6.2.2.1.4 OXYMORPHONE 67
    - 6.2.2.1.5 OTHERS 67
  - 6.2.2.2 PARTIAL MU AGONIST 67
    - 6.2.2.2.1 BUPRENORPHINE 67
    - 6.2.2.2.2 OTHERS 68
  - 6.2.2.3 KAPPA AGONIST MU ANTAGONIST 68
    - 6.2.2.3.1 BUTORPHANOL 68
    - 6.2.2.3.2 OTHERS 68
6.3 CORTICOSTEROIDS 69
- 6.3.1 DEXAMETHASONE 69
- 6.3.2 PREDNISOLONE 69
- 6.3.3 PREDNISONE 69
- 6.3.4 OTHERS 70
6.4 ALPHA 2 AGONISTS 70

7 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 71

7.1 OVERVIEW 72
7.2 BRANDED 73
7.3 GENERIC 73

8 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 74

8.1 OVERVIEW 75
8.2 PRESCRIPTION BASED 76
8.3 OTC 76

9 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 77

9.1 OVERVIEW 78
9.2 COMPANION ANIMAL 79
- 9.2.1 CANINE 80
- 9.2.2 EQUINE 80
- 9.2.3 FELINE 80
- 9.2.4 OTHERS 80
9.3 PRODUCTION ANIMAL 80
- 9.3.1 CATTLE 81
- 9.3.2 SWINE 81
- 9.3.3 POULTRY 81
- 9.3.4 FISH 81
- 9.3.5 OTHERS 81

10 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 82

10.1 OVERVIEW 83
10.2 CHRONIC PAIN 84
10.3 ACUTE PAIN 85
10.4 POST OPERATIVE PAIN 85
10.5 DENTAL PAIN 86

11 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 87

11.1 OVERVIEW 88
11.2 SOLID 89
- 11.2.1 TABLET 89
- 11.2.2 POWDER 90
- 11.2.3 OTHERS 90
11.3 LIQUID 90
- 11.3.1 SOLUTION 90
- 11.3.2 SYRUP 91
- 11.3.3 SUSPENSION 91
- 11.3.4 OTHERS 91
11.4 SEMI SOLID 91
- 11.4.1 GEL 92
- 11.4.2 CREAM 92
- 11.4.3 OTHERS 92

12 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 93

12.1 OVERVIEW 94
12.2 PARENTERAL 95
12.3 ORAL 96
12.4 TOPICAL 96

13 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER 97

13.1 OVERVIEW 98
13.2 VETERINARY HOSPITALS 99
13.3 VETERINARY CLINICS 100
13.4 PET SHOPS 100
13.5 ANIMAL FARMS 101
13.6 ACADEMIC & RESEARCH INSTITUTES 101
13.7 OTHERS 102

14 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 103

14.1 EUROPE 104
- 14.1.1 GERMANY 112
- 14.1.2 FRANCE 119
- 14.1.3 U K 126
- 14.1.4 ITALY 133
- 14.1.5 SPAIN 140
- 14.1.6 NETHERLANDS 147
- 14.1.7 RUSSIA 154
- 14.1.8 SWITZERLAND 161
- 14.1.9 POLAND 168
- 14.1.10 BELGIUM 175
- 14.1.11 TURKEY 182
- 14.1.12 SWEDEN 189
- 14.1.13 DENMARK 196
- 14.1.14 NORWAY 203
- 14.1.15 FINLAND 210
- 14.1.16 REST OF EUROPE 217

15 EUROPE VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 224

15.1 COMPANY SHARE ANALYSIS: EUROPE 224

16 SWOT ANALYSIS 225

17 COMPANY PROFILE 226

17.1 ZOETIS SERVICES LLC 226
- 17.1.1 COMPANY SNAPSHOT 226
- 17.1.2 COMPANY SHARE ANALYSIS 226
- 17.1.3 PRODUCT PORTFOLIO 227
- 17.1.4 RECENT DEVELOPMENTS 227
17.2 ELANCO 228
- 17.2.1 COMPANY SNAPSHOT 228
- 17.2.2 REVENUE ANALYSIS 228
- 17.2.3 COMPANY SHARE ANALYSIS 229
- 17.2.4 PRODUCT PORTFOLIO 229
- 17.2.5 RECENT DEVELOPMENT 229
17.3 MERCK & CO., INC. 230
- 17.3.1 COMPANY SNAPSHOT 230
- 17.3.2 REVENUE ANALYSIS 230
- 17.3.3 COMPANY SHARE ANALYSIS 231
- 17.3.4 PRODUCT PORTFOLIO 231
- 17.3.5 RECENT DEVELOPMENT 231
17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 232
- 17.4.1 COMPANY SNAPSHOT 232
- 17.4.2 COMPANY SHARE ANALYSIS 232
- 17.4.3 PRODUCT PORTFOLIO 233
- 17.4.4 RECENT DEVELOPMENT 233
17.5 VETOQUINOL 234
- 17.5.1 COMPANY SNAPSHOT 234
- 17.5.2 REVENUE ANALYSIS 234
- 17.5.3 COMPANY SHARE ANALYSIS 235
- 17.5.4 PRODUCT PORTFOLIO 235
- 17.5.5 RECENT DEVELOPMENTS 235
17.6 BIMEDA, INC. 237
- 17.6.1 COMPANY SNAPSHOT 237
- 17.6.2 PRODUCT PORTFOLIO 237
- 17.6.3 RECENT DEVELOPMENT 237
17.7 CEVA ANIMAL HEALTH, LLC 238
- 17.7.1 COMPANY SNAPSHOT 238
- 17.7.2 PRODUCT PORTFOLIO 238
- 17.7.3 RECENT DEVELOPMENT 238
17.8 CHANELLE PHARMA 239
- 17.8.1 COMPANY SNAPSHOT 239
- 17.8.2 PRODUCT PORTFOLIO 239
- 17.8.3 RECENT DEVELOPMENT 239
17.9 DECHRA PHARMACEUTICALS PLC 240
- 17.9.1 COMPANY SNAPSHOT 240
- 17.9.2 REVENUE ANALYSIS 240
- 17.9.3 PRODUCT PORTFOLIO 241
- 17.9.4 RECENT DEVELOPMENTS 241
17.10 DURVET ANIMAL HEALTH PRODUCTS 242
- 17.10.1 COMPANY SNAPSHOT 242
- 17.10.2 PRODUCT PORTFOLIO 242
- 17.10.3 RECENT DEVELOPMENT 242
17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 243
- 17.11.1 COMPANY SNAPSHOT 243
- 17.11.2 PRODUCT PORTFOLIO 243
- 17.11.3 RECENT DEVELOPMENTS 243
17.12 NORBROOK 245
- 17.12.1 COMPANY SNAPSHOT 245
- 17.12.2 PRODUCT PORTFOLIO 245
- 17.12.3 RECENT DEVELOPMENT 245
17.13 VIRBAC 246
- 17.13.1 COMPANY SNAPSHOT 246
- 17.13.2 REVENUE ANALYSIS 246
- 17.13.3 PRODUCT PORTFOLIO 247
- 17.13.4 RECENT DEVELOPMENT 247

18 QUESTIONNAIRE 248

19 RELATED REPORTS 252

LIST OF TABLES

TABLE 1 BRAND REVENUE ANALYSIS FOR VETERINARY PAIN MANAGEMENT MARKET 53
TABLE 2 NUMBER OF U.S. HOUSEHOLD-OWNED PET ANIMALS 56
TABLE 3 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
TABLE 4 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
TABLE 5 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
TABLE 6 EUROPE ANTI- INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 65
TABLE 7 EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
TABLE 8 EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 66
TABLE 9 EUROPE PARTIAL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 67
TABLE 10 EUROPE KAPPA AGONIST MU ANTAGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 68
TABLE 11 EUROPE CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 69
TABLE 12 EUROPE CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 69
TABLE 13 EUROPE ALPHA-2 AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 70
TABLE 14 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 73
TABLE 15 EUROPE BRANDED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 16 EUROPE GENERIC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 73
TABLE 17 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 76
TABLE 18 EUROPE PRESCRIPTION BASED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 19 EUROPE OTC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
TABLE 20 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 79
TABLE 21 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 79
TABLE 22 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 79
TABLE 23 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 80
TABLE 24 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 81
TABLE 25 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 84
TABLE 26 EUROPE CHRONIC PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 84
TABLE 27 EUROPE ACUTE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 28 EUROPE POST OPERATIVE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 29 EUROPE DENTAL PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
TABLE 30 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 89
TABLE 31 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 89
TABLE 32 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 89
TABLE 33 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 90
TABLE 34 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 90
TABLE 35 EUROPE SEMI SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 36 EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 91
TABLE 37 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 95
TABLE 38 EUROPE PARENTERAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 39 EUROPE ORAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 40 EUROPE TOPICAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 41 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 99
TABLE 42 EUROPE VETERINARY HOSPITALS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
TABLE 43 EUROPE VETERINARY CLINICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 44 EUROPE PET SHOPS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 100
TABLE 45 EUROPE ANIMAL FARMS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 46 EUROPE ACADEMIC & RESEARCH INSTITUTES IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 101
TABLE 47 EUROPE OTHERS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 48 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 104
TABLE 49 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 50 EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 51 EUROPE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 52 EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 53 EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 54 EUROPE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 55 EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 56 EUROPE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 57 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 58 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 108
TABLE 59 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 60 EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 61 EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 62 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 109
TABLE 63 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
TABLE 64 EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
TABLE 65 EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 110
TABLE 66 EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 111
TABLE 67 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 111
TABLE 68 EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 111
TABLE 69 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 70 GERMANY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 71 GERMANY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 72 GERMANY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 73 GERMANY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 74 GERMANY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 75 GERMANY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 76 GERMANY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 77 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 78 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 115
TABLE 79 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 80 GERMANY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 81 GERMANY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 82 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 116
TABLE 83 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 116
TABLE 84 GERMANY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
TABLE 85 GERMANY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
TABLE 86 GERMANY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 117
TABLE 87 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 118
TABLE 88 GERMANY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 89 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 90 FRANCE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 91 FRANCE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 92 FRANCE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 93 FRANCE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 94 FRANCE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 95 FRANCE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 96 FRANCE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 97 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 98 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 122
TABLE 99 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 100 FRANCE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 101 FRANCE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 102 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 123
TABLE 103 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
TABLE 104 FRANCE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
TABLE 105 FRANCE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 124
TABLE 106 FRANCE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 125
TABLE 107 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 125
TABLE 108 FRANCE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 109 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 110 U.K. ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 111 U.K. ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 112 U.K. OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 113 U.K. MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 114 U.K. PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 115 U.K. KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 116 U.K. CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 117 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 118 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 129
TABLE 119 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 120 U.K. COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 121 U.K. PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 122 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 130
TABLE 123 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 130
TABLE 124 U.K. SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
TABLE 125 U.K. LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
TABLE 126 U.K. SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 131
TABLE 127 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 132
TABLE 128 U.K. VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
TABLE 129 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 130 ITALY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 131 ITALY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 132 ITALY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 133 ITALY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 134 ITALY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 135 ITALY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 136 ITALY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 137 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 138 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 136
TABLE 139 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 140 ITALY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 141 ITALY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 137
TABLE 142 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 137
TABLE 143 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 137
TABLE 144 ITALY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
TABLE 145 ITALY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
TABLE 146 ITALY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 138
TABLE 147 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 139
TABLE 148 ITALY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 139
TABLE 149 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 150 SPAIN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 151 SPAIN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 152 SPAIN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 153 SPAIN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 154 SPAIN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 155 SPAIN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 156 SPAIN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 157 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 158 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 143
TABLE 159 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 160 SPAIN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 161 SPAIN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 162 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 144
TABLE 163 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 144
TABLE 164 SPAIN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
TABLE 165 SPAIN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
TABLE 166 SPAIN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 145
TABLE 167 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 146
TABLE 168 SPAIN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 169 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 170 NETHERLANDS ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 171 NETHERLANDS ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 172 NETHERLANDS OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 173 NETHERLANDS MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 174 NETHERLANDS PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 175 NETHERLANDS KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 176 NETHERLANDS CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 177 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 178 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 150
TABLE 179 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 180 NETHERLANDS COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 181 NETHERLANDS PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 182 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 151
TABLE 183 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
TABLE 184 NETHERLANDS SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
TABLE 185 NETHERLANDS LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 152
TABLE 186 NETHERLANDS SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 153
TABLE 187 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 153
TABLE 188 NETHERLANDS VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 153
TABLE 189 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 190 RUSSIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 191 RUSSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 154
TABLE 192 RUSSIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 193 RUSSIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 194 RUSSIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 155
TABLE 195 RUSSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 196 RUSSIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 197 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 156
TABLE 198 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 157
TABLE 199 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 157
TABLE 200 RUSSIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 157

TABLE 201 RUSSIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 158
TABLE 202 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 158
TABLE 203 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 158
TABLE 204 RUSSIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
TABLE 205 RUSSIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
TABLE 206 RUSSIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 159
TABLE 207 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 160
TABLE 208 RUSSIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
TABLE 209 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 210 SWITZERLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 211 SWITZERLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 161
TABLE 212 SWITZERLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 213 SWITZERLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 214 SWITZERLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 162
TABLE 215 SWITZERLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 216 SWITZERLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 217 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 163
TABLE 218 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 164
TABLE 219 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 220 SWITZERLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 164
TABLE 221 SWITZERLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 165
TABLE 222 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 165
TABLE 223 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
TABLE 224 SWITZERLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
TABLE 225 SWITZERLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 166
TABLE 226 SWITZERLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 167
TABLE 227 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 167
TABLE 228 SWITZERLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
TABLE 229 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 230 POLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 231 POLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 168
TABLE 232 POLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 233 POLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 234 POLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 169
TABLE 235 POLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 236 POLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 237 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 170
TABLE 238 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 171
TABLE 239 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 240 POLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 171
TABLE 241 POLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 172
TABLE 242 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 172
TABLE 243 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
TABLE 244 POLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
TABLE 245 POLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 173
TABLE 246 POLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 174
TABLE 247 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 174
TABLE 248 POLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 174
TABLE 249 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 250 BELGIUM ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 251 BELGIUM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 175
TABLE 252 BELGIUM OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 253 BELGIUM MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 254 BELGIUM PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 176
TABLE 255 BELGIUM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 256 BELGIUM CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 257 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 177
TABLE 258 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 178
TABLE 259 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 178
TABLE 260 BELGIUM COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 178
TABLE 261 BELGIUM PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 179
TABLE 262 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 179
TABLE 263 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
TABLE 264 BELGIUM SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
TABLE 265 BELGIUM LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 180
TABLE 266 BELGIUM SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 181
TABLE 267 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 181
TABLE 268 BELGIUM VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 181
TABLE 269 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 270 TURKEY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 271 TURKEY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 182
TABLE 272 TURKEY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
TABLE 273 TURKEY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
TABLE 274 TURKEY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 183
TABLE 275 TURKEY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 276 TURKEY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 277 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 184
TABLE 278 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 185
TABLE 279 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 280 TURKEY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 185
TABLE 281 TURKEY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 186
TABLE 282 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 186
TABLE 283 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 186
TABLE 284 TURKEY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
TABLE 285 TURKEY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
TABLE 286 TURKEY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 187
TABLE 287 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 188
TABLE 288 TURKEY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 188
TABLE 289 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 290 SWEDEN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 291 SWEDEN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 189
TABLE 292 SWEDEN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 293 SWEDEN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 294 SWEDEN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 190
TABLE 295 SWEDEN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 296 SWEDEN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 297 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 191
TABLE 298 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 192
TABLE 299 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 300 SWEDEN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 192
TABLE 301 SWEDEN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 193
TABLE 302 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 193
TABLE 303 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 193
TABLE 304 SWEDEN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
TABLE 305 SWEDEN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
TABLE 306 SWEDEN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 194
TABLE 307 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 195
TABLE 308 SWEDEN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 195
TABLE 309 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 310 DENMARK ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 311 DENMARK ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 196
TABLE 312 DENMARK OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 313 DENMARK MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 314 DENMARK PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 197
TABLE 315 DENMARK KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
TABLE 316 DENMARK CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 198
TABLE 317 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 198
TABLE 318 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 199
TABLE 319 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 320 DENMARK COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 199
TABLE 321 DENMARK PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 200
TABLE 322 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 200
TABLE 323 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 200
TABLE 324 DENMARK SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
TABLE 325 DENMARK LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
TABLE 326 DENMARK SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 201
TABLE 327 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 202
TABLE 328 DENMARK VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 202
TABLE 329 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
TABLE 330 NORWAY ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
TABLE 331 NORWAY ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 203
TABLE 332 NORWAY OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 333 NORWAY MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 334 NORWAY PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 204
TABLE 335 NORWAY KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 336 NORWAY CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 337 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 205
TABLE 338 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 206
TABLE 339 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 340 NORWAY COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 206
TABLE 341 NORWAY PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 207
TABLE 342 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 207
TABLE 343 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
TABLE 344 NORWAY SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
TABLE 345 NORWAY LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 208
TABLE 346 NORWAY SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 209
TABLE 347 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 209
TABLE 348 NORWAY VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 209
TABLE 349 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 350 FINLAND ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 351 FINLAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 210
TABLE 352 FINLAND OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 353 FINLAND MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 354 FINLAND PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 211
TABLE 355 FINLAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 212
TABLE 356 FINLAND CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 212
TABLE 357 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 212
TABLE 358 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 213
TABLE 359 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 213
TABLE 360 FINLAND COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 213
TABLE 361 FINLAND PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 214
TABLE 362 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 214
TABLE 363 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
TABLE 364 FINLAND SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
TABLE 365 FINLAND LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 215
TABLE 366 FINLAND SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 216
TABLE 367 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 216
TABLE 368 FINLAND VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 216
TABLE 369 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
TABLE 370 REST OF EUROPE ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
TABLE 371 REST OF EUROPE ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 217
TABLE 372 REST OF EUROPE OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
TABLE 373 REST OF EUROPE MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
TABLE 374 REST OF EUROPE PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 218
TABLE 375 REST OF EUROPE KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 219
TABLE 376 REST OF EUROPE CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 219
TABLE 377 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 219
TABLE 378 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 220
TABLE 379 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 380 REST OF EUROPE COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 220
TABLE 381 REST OF EUROPE PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 221
TABLE 382 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 221
TABLE 383 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 221
TABLE 384 REST OF EUROPE SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
TABLE 385 REST OF EUROPE LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
TABLE 386 REST OF EUROPE SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 222
TABLE 387 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 223
TABLE 388 REST OF EUROPE VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 223

LIST OF FIGURES

FIGURE 1 EUROPE VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 35
FIGURE 2 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DATA TRIANGULATION 38
FIGURE 3 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DROC ANALYSIS 39
FIGURE 4 EUROPE VETERINARY PAIN MANAGEMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 40
FIGURE 5 EUROPE VETERINARY PAIN MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS 40
FIGURE 6 EUROPE VETERINARY PAIN MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS 41
FIGURE 7 EUROPE VETERINARY PAIN MANAGEMENT MARKET: MARKET END USER COVERAGE GRID 42
FIGURE 8 EUROPE VETERINARY PAIN MANAGEMENT MARKET: DBMR MARKET POSITION GRID 44
FIGURE 9 EUROPE VETERINARY PAIN MANAGEMENT MARKET: VENDOR SHARE ANALYSIS 45
FIGURE 10 EUROPE VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 49
FIGURE 11 INCREASING PET OWNERSHIP AND ADVANCEMENTS IN VETERINARY MEDICINE ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET FROM 2023 TO 2030 50
FIGURE 12 THE ANALGESICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE VETERINARY PAIN MANAGEMENT MARKET IN 2023 & 2030 50
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR EUROPE VETERINARY PAIN MANAGEMENT MARKET 55
FIGURE 14 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY PRODUCT TYPE, 2022 63
FIGURE 15 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY DRUG TYPE, 2022 72
FIGURE 16 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY MODE OF PURCHASE, 2022 75
FIGURE 17 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY ANIMAL TYPE, 2022 78
FIGURE 18 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY PAIN SOURCE, 2022 83
FIGURE 19 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY DOSAGE, 2022 88
FIGURE 20 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY ROUTE OF ADMINISTRATION, 2022 94
FIGURE 21 EUROPE VETERINARY PAIN MANAGEMENT MARKET: BY END USER, 2022 98
FIGURE 22 EUROPE VETERINARY PAIN MANAGEMENT MARKET: COMPANY SHARE 2022 (%) 224